Clinical Trial Update: A Study of Samuraciclib in Combination With Fulvestrant in Metastatic or Locally Advanced Breast Cancer in Adult Participants [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial evaluating samuraciclib in combination with fulvestrant for metastatic or locally advanced breast cancer has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer

Drugs mentioned

• Faslodex (fulvestrant)
• Samuraciclib (samuraciclib)

Snippet

Sponsor: Carrick Therapeutics Limited | Conditions: Metastatic Breast Cancer, Locally Advanced Breast Cancer | Phase 2 | Status: COMPLETED